Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival

Authors:
  • IGInternational Nasopharynx Cancer Study Group
    International Nasopharynx Cancer Study Group
  • VTVumca I Trial
    Vumca I Trial

Abstract
No abstract available

This publication has 32 references indexed in Scilit: